¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023 : 2023-12-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023 : 2023-12-09
±³À°ÀÏÀÚ : 2023-12-09
±³À°Àå¼Ò : ½ÅÃÌ ¼¼ºê¶õ½ºº´¿ø Á¾ÇÕ°ü 337È£

±³À°ÁÖÁ¦ : Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023

ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
´ã´çÀÚ : ±è¼Ò¿¬
¿¬¶ôó : 070-4105-5373  

À̸ÞÀÏ : sykim1212@yuhs.ac

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:00~09:20 A Journey Through Time: Understanding the Evolution of Clinical Features in Pulmonary Hypertension Stephan Rosenkranz(Heart Center at the University of Cologne)

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:20~09:40 Key Considerations in Diagnosing and Managing Pulmonary Hypertension in the Elderly Á¤ÀÎÇö(¿ëÀμ¼ºê¶õ½ºº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 09:40~10:00 From Guidelines to Practice: How Recent Guidelines Reflect Changes in Pulmonary Hypertension ¹ÚÀçÇü(Ãæ³²´ëº´¿ø )

Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:00~10:30 Åä·Ð(Session 1. Evolution of PH patients & clinical practice in PH) ³ªÁø¿À, ¹è´ëȯ, ±è¾ç±â, Àü°æ¸¸(°í´ë±¸·Îº´¿ø, ÃæºÏ´ëº´¿ø, ¼øõÇâ´ë ¼­¿ïº´¿ø, »ï¼º¼­¿ïº´¿ø)

ÈÞ½Ä 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:30~10:50 ÈÞ½Ä ()

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 10:50~11:20 How to differentiate between Group 1 (PAH with lung disease) and Group 3 (PH due to lung disease) Marc Humbert(Faculte du Medecine-Universite Paris-Saclay)

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 11:20~11:40 Management of Pulmonary Hypertension in Interstitial Lung Disease Patients: When to Evaluate, How to Treat? ¹Ú¹«¼®(¼¼ºê¶õ½ºº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 11:40~12:00 Sleep-related breathing disorder, Obesity and Pulmonary hypertension °­ÁöÀº(ÀÏ»ê¹éº´¿ø )

Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 12:00~12:30 Åä·Ð(Session 2. When patients have PH and lung disease) Çã¶õ, ÃÖÁ¤Çö, ÀåÇ×Á¦, ¹ÚÁö¸í(ÇѾç´ëº´¿ø, ºÎ»ê´ëº´¿ø, ÇØ¿î´ëº´¿ø, ¼­¿ï´ëº´¿ø)

½Ä»ç 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 12:30~13:30 ½Ä»ç ()

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 13:30~14:00 How to differentiate between Group 1 (PAH with heart disease) and Group 2 ¼­Áö¿ø(°­³²¼¼ºê¶õ½ºº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:00~14:20 Management of PH with Heart failure À±Á¾Âù(¼­¿ï¼º¸ðº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:20~14:40 Key Considerations in PH patients with valvular heart disease ±è´ëÈñ(¼­¿ï¾Æ»êº´¿ø )

Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 14:40~15:10 Åä·Ð(Session 3. When patients have PH and heart disease) ¼±º´ÁÖ, ±è¹Ì³ª, ±è¼öÇö, ȲÇå±Ô(¼­¿ï¾Æ»êº´¿ø, °í´ë¾È¾Ïº´¿ø, ¼­¿ïÀÇ·á¿ø, ¼øõÇâ´ë ±¸¹Ìº´¿ø)

ÈÞ½Ä 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:10~15:30 ÈÞ½Ä ()

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:30~15:45 Case from Asan Medical Center °­µµÀ±(¼­¿ï¾Æ»êº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 15:45~16:00 Case from Samsung Medical Center ±èÁöÈÆ(»ï¼º¼­¿ïº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:00~16:15 Case from Seoul Nat ¹ÚÁØ¿ø(¼­¿ï´ëº´¿ø )

±³À°½Ã°£ 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:15~16:30 Case from Severance Hospital ¿ì¾Æ¶ó(¼¼ºê¶õ½ºº´¿ø )

Åä·Ð 12¿ù 09ÀÏ Á¾ÇÕ°ü 3Ãþ 337È£ 16:30~17:00 Åä·Ð(Session 4. Interactive Case Discussion) Á¤¹ÌÇâ, ÀÌÁÖÈñ, ³ª½Â¿ø, ÃÖ¿øÀÏ(¼­¿ï¼º¸ðº´¿ø, ÃæºÏ´ëº´¿ø, ¿ï»ê´ëº´¿ø, ¸íÁöº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦3ȸ ¼¼ºê¶õ½º¡¤¾Æ»ê Æó°íÇ÷¾Ð °øµ¿ ½ÉÆ÷Áö¾ö PH ACADEMY 2023 : 2023-12-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦ 10ȸ ºÎ»ê´ëÇб³º´¿ø ±Ç¿ªÈ£Èí±âÀü¹®Áúȯ¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2023-12-09
´ÙÀ½±Û °­ºÏ»ï¼ºº´¿ø 2023³â ÇϹݱâ À¯¹æ∙°©»ó¼± ¾Ï À¥ ½ÉÆ÷Áö¾ö : 2023-12-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 49 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 43 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 39 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 51 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 38 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 74 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 28 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 41 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 38 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 45 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 44 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 32 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 36 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 41 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 45 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷